Pregled bibliografske jedinice broj: 629633
The effect of methamphetamine on ataxia and brain malondialdehyde levels in rat model of dopaminergic neurotoxicity
The effect of methamphetamine on ataxia and brain malondialdehyde levels in rat model of dopaminergic neurotoxicity // 4th Croatian Congress of Toxicology with international participation (CROTOX 2012) : meeting abstracts ; u: Arhiv za higijenu rada i toksikologiju 63 (2012) (S2) ; Poster presentations / Želježić, Davor (ur.) (ur.).
Zagreb: Institut za medicinska istraživanja i medicinu rada, 2012. str. 00-00 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 629633 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The effect of methamphetamine on ataxia and brain malondialdehyde levels in rat model of dopaminergic neurotoxicity
Autori
Šuran, Jelena
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
4th Croatian Congress of Toxicology with international participation (CROTOX 2012) : meeting abstracts ; u: Arhiv za higijenu rada i toksikologiju 63 (2012) (S2) ; Poster presentations
/ Želježić, Davor (ur.) - Zagreb : Institut za medicinska istraživanja i medicinu rada, 2012, 00-00
Skup
4th Croatian Congress of Toxicology with international participation (CROTOX 2012)
Mjesto i datum
Primošten, Hrvatska, 02.05.2012
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
methamphetamine; dopaminergic neurotoxicity; ataxia; malondialdehyde
Sažetak
A single, neurotoxic methamphetamine dose administered to rat represents a valuable rodent model of dopaminergic neurodegeneration whose pathogenesis is associated with lipid peroxidation in brain, especially in nigrostriatum, and is characterized by ataxia and impaired motorics. The effect of three neurotoxic doses of methamphetamine (10, 20 and 40 mg/kg b.w., s.c.) on development of ataxia and malondialdehyde (MDA) levels in striatum, frontal cortex, cortex, hippocampus, diencephalon and cerebellum of thirty Wistar rats was evaluated. Atactic phenotype was scored 24 hours after methamphetamine administration. Total MDA in brain tissue supernatants was measured using high performance liquid chromatography with UV detection. Atactic phenotype was dose dependent, being more pronounced in animals administered 40 mg/kg (9 ± 2, mean score ± SD) in comparison to animals administered 20 mg/kg (8.25 ± 0.9) and 10 mg/kg (7 ± 1.4) of methamphetamine. Methamphetamine decreased levels of MDA in most of the brain regions ; lowest level was measured 2 hours after methamphetamine dose of 40 mg/kg in striatum (12.8 ± 2.4 nmol/g of tissue) in comparison to saline-injected control (27.2 ± 2.6 nmol/g of tissue), but it increased 24 hours later (24.9 ± 4.4 nmol/g tissue). Similar trend was present after methamphetamine doses of 20 mg/kg and 10 mg/kg, however mainly without exceeding control levels significantly. These results question the role of MDA in mechanisms of methamphetamine-induced neurotoxicity, but nevertheless confirm the effectiveness of these mechanisms in rendering animal model of monoamine disruption with a pivotal role in development of new therapeutic approaches to Parkinson disease.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
108-1083570-3635 - Pentadekapeptid BPC 157 - daljnja istraživanja (Sikirić, Predrag, MZOS ) ( CroRIS)
Ustanove:
Veterinarski fakultet, Zagreb,
Medicinski fakultet, Zagreb
Profili:
Jelena Šuran
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE